As of June 17, 2025, Constellation Pharmaceuticals Inc (CNST) reports a Current Ratio of 14.05.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Constellation Pharmaceuticals Inc's Current Ratio
Over recent years, Constellation Pharmaceuticals Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2020-12-31 | 14.05 |
| 2019-12-31 | 16.97 |
| 2018-12-31 | 7.98 |
| 2017-12-31 | 1.59 |
| 2016-12-31 | 3.09 |
This fluctuation highlights how Constellation Pharmaceuticals Inc manages its short-term assets and liabilities over time.
Comparing Constellation Pharmaceuticals Inc's Current Ratio to Peers
To better understand Constellation Pharmaceuticals Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Constellation Pharmaceuticals Inc (CNST) | 14.05 |
| Forward Pharma A/S (FWP) | 117.44 |
| PZ Wind Down Inc (PZRXQ) | 7.99 |
| Phio Pharmaceuticals Corp (PHIO) | 5.63 |
| Regeneron Pharmaceuticals Inc (REGN) | 4.73 |
| Moderna Inc (MRNA) | 3.67 |
Compared to its competitors, Constellation Pharmaceuticals Inc's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.